A single third-trimester sFlt-1/PlGF ratio measurement can predict late-onset preeclampsia and FGR with a sensitivity and specificity of 84.4% and 93.0%, respectively.32 A recent meta-analysis and systematic review also concluded that the sFlt-1/PlGF ratio can prove a valuable screening tool for preeclampsia, helping in decision-making, treatment stratification, and better resource allocation.29 Here, PGF is linked to preeclampsia.